Small molecules, such as nitric oxide (NO) and hydrogen peroxide (H 2 O 2 ), regulate cellular signalling via interactions with proteins containing redox-active metals and/or cysteine residues. Of these molecules, NO-formed from l-arginine by endothelial nitric oxide synthase-is an important regulator of vascular tone 7 . Sustained increases in NO synthesis by inducible nitric oxide synthase, as observed in pathological settings such as sepsis, are associated with profound hypotension 8 . Paradoxically, inhibitors of the NO pathway have generally failed to ameliorate severe septic shock 9,10 , which suggests involvement of additional mediators of hypotension.
1
O 2 and whether this contributes to blood pressure control have remained unknown. Here we show that arterial indoleamine 2,3-dioxygenase 1 regulates blood pressure via formation of 1 O 2 . We observed that in the presence of hydrogen peroxide, the enzyme generates 1 O 2 and that this is associated with the stereoselective oxidation of l-tryptophan to a tricyclic hydroperoxide via a previously unrecognized oxidative activation of the dioxygenase activity. The tryptophan-derived hydroperoxide acts in vivo as a signalling molecule, inducing arterial relaxation and decreasing blood pressure; this activity is dependent on Cys42 of protein kinase G1α. Our findings demonstrate a pathophysiological role for 1 O 2 in mammals through formation of an amino acid-derived hydroperoxide that regulates vascular tone and blood pressure under inflammatory conditions.
Small molecules, such as nitric oxide (NO) and hydrogen peroxide (H 2 O 2 ), regulate cellular signalling via interactions with proteins containing redox-active metals and/or cysteine residues. Of these molecules, NO-formed from l-arginine by endothelial nitric oxide synthase-is an important regulator of vascular tone 7 . Sustained increases in NO synthesis by inducible nitric oxide synthase, as observed in pathological settings such as sepsis, are associated with profound hypotension 8 . Paradoxically, inhibitors of the NO pathway have generally failed to ameliorate severe septic shock 9, 10 , which suggests involvement of additional mediators of hypotension.
On the basis of functional similarity with the metabolism of l-arginine by nitric oxide synthase, it has previously been reported that metabolism of l-tryptophan (Trp) to N-formylkynurenine (NFK) and l-kynurenine (Kyn) by endothelial indoleamine 2,3-dioxygenase 1 (IDO1) (Fig. 1a) contributes to the regulation of vascular tone and blood pressure in inflammation, and that a commercial Kyn preparation relaxed pre-constricted arteries 6 . Although these findings have since been confirmed 11, 12 , we found that recently purchased Kyn no longer relaxed arteries, and that high-performance-liquid-chromatograhy (HPLC)-purified Kyn and NFK also failed to relax naive mouse arteries (Extended Data Fig. 1a ). However, purified Trp relaxed pre-constricted mouse abdominal aortas that expressed IDO1, irrespective of whether IDO1 expression was induced in vitro by treating arteries with interferon-γ (IFN-γ) or in vivo by treating mice with lipopolysaccharide (LPS) 6 (Extended Data Fig. 1b, c) . These findings indicate that the 'relaxing factor' derived from Trp is likely to be a metabolite 'upstream' of NFK and that this molecule may have been present as a contaminant in the commercial preparations of Kyn used in the earlier studies.
As O 2 -exposed Trp' dose-dependently relaxed endothelium-denuded naive abdominal aortas that do not express IDO1 (Fig. 1b) . Analysis by HPLC and UV absorption spectroscopy revealed that 1 O 2 -exposed Trp contained eight distinct compounds (labelled peaks 1-8, Fig. 1c ). By comparison to authentic standards, peaks 7 and 8 were identified as NFK and Trp, respectively. Of the remaining six peaks, only peak 6 substantially relaxed naive arteries in a dose-dependent manner when purified (Fig. 1d , Extended Data Fig. 1d ). Purified peak 6 also dose-dependently relaxed conduit and resistance arteries from mouse, rat and pig (Extended Data Fig. 1e-i ), which indicates that 1 O 2 -mediated oxidation of Trp generates a compound that relaxes arteries in a vascular-bed and species-independent manner.
To identify the compound eluting in peak 6, we analysed 1 O 2 -exposed Trp by liquid chromatography-mass spectrometry (LC-MS). The compounds eluting in peaks 5 and 6 had a molecular mass of 236 (single ions with mass-to-charge ratio (m/z) 237), whereas the compounds eluting in peaks 2 and 4 had a m/z of 221 (Extended Data Fig. 2a ). This suggests the incorporation into Trp (m/z 205) of two oxygen atoms in the compounds eluting in peaks 5 and 6, and one oxygen atom in the compounds eluting in peaks 2 and 4. Tandem mass spectrometry (MS/MS) fragmentation spectra (Extended Data Fig. 2b ) indicated that the compounds in each pair of peaks were isomers. Analysis by 1 H and 13 C nuclear magnetic resonance (NMR) suggested that the molecules eluting in peaks 5 and 6 are tricyclic Trp-derived hydroperoxides that have O 2 incorporated 4 at C3a, and the molecules eluting in peaks 2 and 4 are the corresponding tricyclic hydroxides of Trp (transand cis-WOH, respectively) (Extended Data Table 1 ). We confirmed that the compounds in peaks 5 and 6 were hydroperoxides by HPLC with post-column chemiluminescence detection 14 (Extended Data Fig. 2c ). Chemical reduction eliminated the chemiluminescence response of these compounds (Extended Data Fig. 2d ) and resulted in retention times, molecular ions and fragmentation patterns, and 1 H NMR spectra identical to those of peaks 2 and 4, respectively (Extended Data Fig. 3a, b) .
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These data confirm that peaks 2 and 4 contain the hydroxides of the corresponding hydroperoxides in peaks 5 and 6.
To unequivocally assign the stereochemistry of the molecules eluting in peaks 5 and 6, we performed nuclear Overhauser effect (NOE)-difference NMR on the corresponding stable hydroxides in peaks 2 and 4. Irradiation of the resonance at about 5.2 p.p.m., corresponding to proton H8a in the 1 H NMR of purified peaks 2 and 4, resulted in a clear NOE signal with the Hα (H 2 ) in the case of peak 2 but not peak 4 (Extended Data Fig. 3c-f ). The NOE signal is indicative of protons H8a and H2 being on the same face of the molecule and suggests that peak 2 corresponds to the trans-configured tricyclic hydroxide. From these findings, extensive 2D-NMR analyses and comparison of the NMR data with relevant literature 4, 15 , we concluded that the molecule eluting in peak 6 is the tricyclic Trp-derived cis-hydroperoxide ((2S,3aR, 8aR)-3a-hydroperoxy-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indole-2-carboxylic acid)-hereafter referred to as cis-WOOH-whereas the molecule that eluted in peak 5 is the corresponding 3a,8a-epimer trans-WOOH (Fig. 1a) . Incubation of cis-WOOH at 37 °C and pH 7.4 led to its stoichiometric conversion to NFK, indicated by spectrophotometry, NMR and LC-MS/MS (Extended Data Fig. 4a-c) , establishing cis-WOOH as a precursor of NFK. Thermal decomposition of cis-WOOH also led to emission of light with maxima at 489 nm, characteristic of activated carbonyls 16 (Extended Data Fig. 4d ). On the basis of these findings and known chemistry 4 , we propose a plausible scheme for 1 O 2 -mediated conversion of Trp to cis-WOOH (Extended Data Fig. 4e ).
IDO1 is known to require reduction of its Fe 3+ -haem prosthetic group to Fe 2+ -haem for activity 17 . Using superoxide radical anion (O 2
•-) or cytochrome b 5 -cytochrome P450 reductase as a reducing system 18 , IDO1 converted Trp to NFK and small amounts of cis-WOH, but not cis-WOOH (Fig. 2a , top and middle), which demonstrates that cis-WOOH is not a product of reductively activated IDO1 activity. Because inflammation is associated with increased H 2 O 2 and IDO1 also possesses peroxidase activity 19 , we examined Trp oxidation by IDO1 in the presence of H 2 O 2 . Under these conditions, cis-WOOH was formed as the major product, in addition to NFK, the peroxidase product oxyindolylalanine 20 and trace amounts of trans-WOOH ( Fig. 2a  bottom, Fig. 2b ). By contrast, oxidation of Trp with chemically generated 1 O 2 yielded more comparable amounts of cis-and trans-WOOH (Extended Data Fig. 5a, b (Fig. 2c) . This demonstrated that the two oxygen atoms inserted into Trp to form cis-WOOH are derived from O 2 rather than H 2 O 2 . Saturating the reaction mixture with O 2 caused a small but significant increase in cis-WOOH, whereas displacing O 2 in the reaction mixture with argon decreased formation of cis-WOOH (and NFK) but not oxyindolylalanine (Extended Data Fig. 5d ), thereby confirming the O 2 dependence of the Trp to cis-WOOH conversion.
To determine whether cis-WOOH is formed in vivo, we pretreated porcine coronary arteries with IFN-γ to increase IDO1 expression 6 and to mimic inflammatory conditions. This treatment increased arterial H 2 O 2 (Fig. 2d ) and led to formation of cis-WOOH, which was detected as arterial conversion of 15 N 2 Trp to 15 N 2 cis-WOOH (Fig. 2e) . Furthermore, addition of catalase conjugated to polyethylene glycol to scavenge arterial H 2 O 2 (but not polyethylene glycol alone) attenuated Trp-induced relaxation of IFN-γ-pretreated mouse arteries (Extended Data Fig. 5e ). These data suggest that under inflammatory conditions arteries produce cis-WOOH from Trp.
We next examined whether IDO1 in the presence of H 2 O 2 generates 1 O 2 . Addition of H 2 O 2 to Singlet Oxygen Sensor Green (SOSG) and IDO1 resulted in an immediate increase in fluorescence characteristic of the 1 O 2 -specific SOSG endoperoxide that was absent in the presence of Trp or when IDO1 was replaced with albumin (Extended Data Fig. 5f ). Similarly, IDO1-H 2 O 2 converted anthracene-9, 10-diyldiethane-2,1-diyl disulfate disodium salt (EAS) 16 to its 1 O 2 -specific endoperoxide, EAS-O 2 (Extended Data Fig. 5g ). Unambiguous evidence for the formation of 1 O 2 by IDO1-H 2 O 2 was obtained using near-infrared emission at 1,270 nm, which corresponds to the singletdelta state monomolecular light-emission decay 22 of 1 O 2 . Addition of active-but not heat-inactivated-IDO1 to H 2 O 2 concentrationdependently increased 1,270-nm emission (Fig. 3a) O 2 ) increased the yield of cis-WOOH relative to that of oxyindolylalanine (Fig. 3b) , whereas the structurally diverse 1 O 2 scavengers l-histidine, SOSG, cis-norbixin and urate decreased the cis-WOOH yield (Fig. 3c) . Moreover, LC-MS-based quantification of IDO1-H 2 O 2 -mediated Data Fig. 5j ). The fact that IDO2 generated cis-WOOH in the presence of H 2 O 2 raises the possibility that IDO2 may also contribute to Trp-induced arterial relaxation under inflammatory conditions. However, Trp-induced relaxation of IFN-γ-pretreated abdominal aortas of Ido1 -/-mice was comparable to that seen in aortas of Ido1
Ido2
-/-mice (Extended Data Fig. 5k ), which indicates that under the conditions tested IDO2 may not contribute meaningfully to arterial relaxation, consistent with the lack of evidence for arterial expression of IDO2 in naive animals or under conditions of inflammation. Experiments probing the mechanism of 1 O 2 generation by IDO1 and H 2 O 2 indicated the involvement of protein peroxy radicals (Extended Data Fig. 6 ) and the Russell mechanism 26 as a possible pathway (Extended Data Fig. 9a) .
To examine the role of 1 O 2 in Trp-induced IDO1-mediated arterial relaxation, we added the 1 O 2 scavengers l-histidine, urate or cis-norbixin to arteries pretreated with IFN-γ. This attenuated relaxation mediated by Trp but not by NO (Fig. 3f , g, Extended Data Fig. 5l ), an effect seen with arteries from wild-type, but not Ido1 -/-, mice (Fig. 3f) . Moreover, the addition of urate to arteries pretreated with IFN-γ resulted in the accumulation of parabanic acid (Fig. 3h) , which indicates that IDO1-expressing arteries form 1 O 2 under conditions that mimic inflammation.
We next focused on the mechanism of cis-WOOH-mediated relaxation of resistance arteries. The cGMP-competitive protein kinase G (PKG) inhibitor RP-8-CPT-cGMP modestly attenuated relaxation, whereas the ATP-competitive PKG inhibitor KT 5823 was more effective (Extended Data Fig. 7a, b) , which suggests that cis-WOOH activates PKG independently of cGMP. PKG1α is known to undergo H 2 O 2 -mediated oxidative dimerization through Cys42, which is associated with enzyme activation 27 . Of note, cis-WOOH, but not trans-WOOH, dimerized purified recombinant human PKG1α, independent of the presence of transition metals and light but dependent on Cys42 of PKG1α (Fig. 4a) . Exposure of resistance arteries of wild-type (Fig. 4b, left) and Ido1 -/-mice (Fig. 4b, right) to cis-WOOH also caused PKG1α dimerization, as was observed with Trp addition to IDO1-expressing arteries (Fig. 4c) . Compared with the wild-type counterparts, mesenteric arteries from PKG1α(C42S) knock-in mice 28 showed blunted relaxation in response to cis-WOOH and Trp (Fig. 4d) , but not the NO donor 2-(N, N-diethylamino)-diazenolate-2-oxide (DEANO) (Extended Data Fig. 7c) .
As Ido1 -/-mice are partially protected from hypotension induced by experimental cerebral malaria and endotoxaemia 6 , we compared systolic blood pressure responses in unconscious endotoxaemic wild-type and PKG1α(C42S) knock-in mice. Infusion of Trp decreased blood pressure temporarily in wild-type but not knock-in mice (Fig. 4e) , Letter reSeArCH whereas IDO activity was comparable between the two genotypes (Extended Data Fig. 7d, e) . In contrast to Trp, the hypotensive response to sodium nitroprusside, which activates PKG1α via the canonical non-oxidative pathway, was comparable in wild-type and PKG1α(C42S) knock-in mice (Fig. 4f) . These data suggest that the Trpinduced decrease in blood pressure of endotoxaemic mice is mediated via non-canonical oxidative activation of PKG1α involving Cys42.
As H 2 O 2 itself can induce arterial relaxation via Cys42-dependent oxidative dimerization of PKG1α, we investigated whether this pathway overlaps with PKG1α oxidation by cis-WOOH by testing the effect of Trp on acetylcholine-induced relaxation of resistant mesenteric arteries, which is mediated by H 2 O 2
29
. Trp and 1-MT had little effect on arteries isolated from naive mice (Fig. 4g) , whereas Trp sensitized-and 1-MT attenuated-relaxation of arteries from endotoxaemic mice (Fig. 4h) . Moreover, addition of Trp to IDO1-expressing human vascular smooth muscle cells enhanced PKG1α dimerization by H 2 O 2 concentrations that alone did not induce measurable dimerization (Extended Data  Fig. 7f ). These findings suggest that under inflammatory conditions, H 2 O 2 -induced arterial relaxation via PKG1α oxidation may be partially mediated by IDO1 and cis-WOOH.
We finally tested a potential role of IDO1 and cis-WOOH in cardiac pathophysiology related to pressure overload, in which PKG1α oxidation has previously been implicated 30 . We found no evidence of IDO1 expression and hence no evidence of it having a role in cardiac tissue after pressure overload (Extended Data Fig. 8a ). By contrast, IDO1 was expressed in conduit arteries with underlying atherosclerosis and in resistance arteries of apolipoprotein E knockout (Apoe
Ido1
-/-mice (Extended Data Fig. 8b, c) . Moreover, IDO1 contributed to the regulation of blood pressure in Apoe -/-but not in Apoe
-/-mice (Extended Data Fig. 8d , e), which indicates that the pathway identified in this study may have a role in regulation of blood pressure in atherosclerosis, an inflammatory disease.
In summary, we have demonstrated that 1 O 2 has an important pathophysiological role in the redox regulation of arterial relaxation and blood pressure in mammals under inflammatory conditions in which -/-mice, n = 4) or Trp (c, arteries from LPS-treated wild-type animals, n = 4). d, Relaxation of pre-constricted mouse mesenteric resistance arteries from wild-type (black) and PKG1α(C42S) knock-in mice (grey) by cis-WOOH (naive arteries, n = 3 for both genotypes), or Trp (n = 4 for both genotypes). e, f, Blood pressure responses elicited by Trp (e), SNP (f) in endotoxaemic wild-type (black, n = 8 for Trp, n = 4 for SNP) or PKG1α(C42S) knock-in mice (grey, n = 9 for Trp and SNP). g, h, Acetylcholine (ACh)-induced relaxation of mouse mesenteric resistance arteries from naive (g) or LPStreated (h) wild-type mice in the absence (control, n = 4 for naive, n = 13 for LPS) or presence of Trp (n = 4 for naive, n = 10 for LPS) or 1-MT (n = 4 for naive, n = 8 for LPS). Data are representative or mean ± s.e.m. *P ≤ 0.05 as determined by Mann-Whitney rank-sum test (a-c), two-way ANOVA with Šidák post hoc test (d), Kruskal-Wallis with Dunn's test (e, f), and oneway ANOVA of maximal relaxation values with Dunnett's test (g, h). 
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METHODS
Reagents
cis-Norbixin was purified from annatto extracts as previously described 37 . In brief, annatto extract (50.0 g) was dissolved in 250 ml of aqueous NaOH (4% w/v) and stirred at 37 °C for 14 h. The solution was then cooled to 0 °C and acidified with HCl to pH = 2 before being extracted with ethyl acetate (4 × 300 ml). This yielded approximately 5.5 g of crude organic soluble material. This crude material was then purified in batches. Fifty milligrams was dissolved in 1 ml DMSO and purified by reversed phase HPLC using a 600 Multisolvent Delivery System (Waters) equipped with a Waters 500 pump, a 2996 photodiode array detector set at 214 and 350 nm, and an XBridge Prep C8 5-μm OBD 30 × 150 mm column eluted at a flow rate of 40 ml min −1 over 25 min using a linear gradient of 40-100 vol% acetonitrile (0.1% trifluoroacetic acid, TFA) in H 2 O (0.1% TFA). Eluting fractions were analysed for cis-norbixin (m/z 381 [M+H] + ) by low-resolution mass spectrometry using a Shimadzu 2020 (electrospray ionization, ESI) LC-MS operating in positive-ion mode. Fractions containing pure product from four HPLC runs were combined and lyophilized to yield cis-norbixin as a red fluffy solid (17 mg, 8.5% recovery from 200 mg crude material). The identity and purity of cis-norbixin (>95%) was confirmed by NMR spectroscopy using a Bruker DRX 500 instrument operating at 500 MHz for 1 H and 125 MHz for 13 C and referenced to the residual DMSO signal. Each proton resonance was assigned according to the following convention: chemical shift (δ), multiplicity, coupling constant (J Hz) and number of protons. In reporting of the spectral data, the following abbreviations are used: s, singlet; d, doublet; t, triplet; q, quartet; m, multiplet. was used. All data were acquired and reference-mass-corrected via a dual-spray ESI source. Each scan or data point on the total ion chromatogram (TIC) is an average of 13,700 transients, producing a spectrum every second. Mass spectra were created by averaging the scans across each peak and background-subtracted against the first 10 s of the TIC. Acquisition was performed using the Agilent Mass Hunter Data Acquisition software v.B.05.00 build 5.0.5042.2, and analysis was performed using Mass Hunter Qualitative Analysis v.B.05.00 build 5.0.519.13. Chromatographic separation was performed using a Zorbax SB-C18 Rapid Resolution HT 2.1 × 50 mm, 1.8-μm column (Agilent Technologies) using an acetonitrile gradient (5-100%) over 3.5 min at 0.5 ml min −1
. High-resolution mass spectrometry. An Agilent 1290 Infinity combined with an Agilent 6224 TOF LC-MS Mass Spectrometer (Agilent Technologies) was used. All data were acquired and reference-mass-corrected via a dual-spray ESI source. Each scan or data point on the TIC is an average of 13,700 transients, producing a spectrum every second. Mass spectra were created by averaging the scans across each peak and subtracting the background from the first 10 s of the TIC. ). 4-Amino-N′-hydroxy-1,2,5-oxadiazole-3-carboximidamide 2. Malononitrile 1 (6.0 g, 90.8 mmol) was added to preheated H 2 O (150 ml, 45 °C) and stirred for 5 min. The resulting solution was cooled in an ice-water bath, and sodium nitrite (6.9 g, 99.9 mmol) was added and the solution stirred for a further 5 min. Then, HCl (10 M, 6.2 ml) was added slowly. After 3 min, the ice-water bath was removed, and the reaction mixture was stirred for 1.5 h at room temperature. Hydroxylamine (9.0 g, 273.5 mmol) was added and the reaction mixture stirred for 1 h, before refluxing for another 2 h and cooling in an ice-water bath. The resulting solution was neutralized to pH 7. The precipitate was collected by filtration, washed well with H 2 O, and dried in a vacuum to give the title compound as a brown solid (11.3 g, 90%). 98 mmol) and NaCl (2.45 g, 41.93 mmol) were added to a mixture of H 2 O (27 ml), acetic acid (15 ml), and HCl (10 M, 7 ml). The suspension was stirred at room temperature until complete solution was achieved and then cooled in an ice-water bath. A solution of sodium nitrite (0.94 g, 13.7 mmol) in water (3.0 ml) was added, and stirred at room temperature overnight. The precipitate was collected by filtration, washed well with H 2 O, taken into EtOAc and dried over MgSO 4 . The suspension was filtered, and the filtrate evaporated to give the title compound as a pale brown solid (1.1 g, 56%). TLC and LC-MS) . The solvent was removed, and the resulting residue was taken up into EtOAc (100 ml) and washed with 1 M HCl (2 × 50 ml). The organic layer was dried over MgSO 4 , filtered and concentrated. The crude product was purified by flash chromatography, eluting with 0-60% EtOAc/petroleum benzine to give the title compound as an off-white solid (0.59 g, 55% N-(2-((4-(4-(3-bromo-4-fluorophenyl)-5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-1,2,5-oxadiazol-3-yl)amino) ethyl)sulfamoylcarbamate. A solution of 6 (0.5 g, 1.47 mmol) and 7 (1.4 g, 4.41 mmol) in dichloromethane was added to trifluoroacetic acid (2.24 ml, 29.2 mmol) and triethylsilane (0.77 ml, 4.82 mmol) dropwise at 0 °C. The reaction mixture was stirred at the same temperature for 2 h (monitored by LC-MS). The reaction mixture was quenched with saturated NaHCO 3 to pH 8 and extracted with EtOAc (3 × 30 ml). The combined organic layers were washed with brine, dried over MgSO 4 , filtered and concentrated. The crude product was purified by flash chromatography, eluting with 0-50 EtOAc/petroleum benzine to give the title compound as a colourless solid (0.68 g, 78% 
N-[2-({4-[4-(3-bromo-4-fluorophenyl)-5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl]-1,2, 5-oxadiazol-3-yl}amino)ethyl]sulfamide 9.
A mixture of 8 and HBr (33 wt. % in acetic acid) (2 ml) was stirred at 0 °C for 1-2 h (monitored by TLC and LC-MS). Acetic acid was removed, and EtOAc and H 2 O were added to the resulting residue and then neutralized. The organic phase was separated, and the aqueous phase was further extracted with EtOAc (2×). The combined organic layers were dried over MgSO 4 filtered and concentrated. The crude product was purified by flash chromatography, eluting with 10-80% EtOAc/petroleum benzine to give the title compound as a colourless solid (0.26 g, 85%). 
N-(3-bromo-4-fluorophenyl)-N′-hydroxy-4-((2-(sulfamoylamino)ethyl)amino)-1,2, 5-oxadiazole-3-carboximidamide (10, epacadostat).
To a solution of 9 (0.17 g, 0.366 mmol) in THF (5 ml) was added NaOH (0.044 g, 1.10 mmol). The mixture was stirred at room temperature for 3 h, before the reaction mixture was acidified to pH 3-4 with 1 M HCl and extracted with EtOAc (3 × 15 ml). The combined organic layers were washed with H 2 O, brine, dried over MgSO 4 , filtered and concentrated. The crude product was purified by flash chromatography, eluting with 0-50% EtOAc/DCM to give the title compound as a colourless solid (0.13 g, 80%). 
HRMS-ESI m/z [M + H]
+ for C 11 H 14 BrFN 7 O 4 S + calculated 437.9990, found 439.9994. HPLC purity >95%, Rt = 5.46 min. Dye-sensitized singlet oxygen oxidation of Trp. Trp (500 mg, 2.45 mmol) was dissolved in H 2 O:EtOH (95:5, 150 ml) in a 500-ml round bottom flask by heating the mixture. After cooling to room temperature, Rose Bengal (4,5,6,7-tetrachloro-2′,4′,5′,7′-tetraiodofluorescein) (7 mg, 0.07 mmol) was added, the reaction mixture cooled to 0 °C and irradiated at this temperature for 9 h using a 500 W halogen lamp (Nelson, model no. MWLT033C) placed at 25 cm from the reaction flask. The reaction mixture was then acidified with acetic acid (99.7%, 1.5 ml), warmed to room temperature, extracted with dichloromethane (2 × 100 ml) to remove Rose Bengal, and the aqueous layer collected and lyophilized. The resulting light brown powder was re-dissolved in H 2 O and subjected to semi-preparative reversed-phase HPLC (5-μm Waters Sunfire C18 column, 10 × 250 mm) to separate the various oxidation products (peaks) by gradient elution using mobile phase A (0.1% acetic acid in H 2 O) and mobile phase B (0.1% acetic acid in acetonitrile) at 6 ml min Enzymatic oxidation of Trp. Recombinant human IDO1 (rhIDO1) encoded by the pQE9-IDO1 plasmid vector was expressed in Escherichia coli as a fusion protein to a hexahistidyl tag and purified as previously described 39, 40 , except that for some preparations, hemin was added instead of 5-aminolevulenic acid as previously described 41 . Different batches of purified rhIDO1 used for the various experiments appeared as a single, major protein band at ~42 kDa on reducing sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and Coomassie blue staining and exhibited 405 to 280 nm absorption ratios of >1.4. The concentration of rhIDO1 was determined spectrophotometrically (Cary 100 spectrophotometer) using ε 405 = 159 mM −1 cm −1 for Fe 3+ -IDO1 (in which ε is the molar absorption coefficient). Recombinant human Fe 3+ -IDO1 protein (2 μM; unless otherwise stated) and Trp (100 μM) were incubated at 25 °C for 15 min in the presence of DTPA (100 μM) and either xanthine oxidase, hypoxanthine and catalase as a source of superoxide 42 , reduced cytochrome b 5 43 or a single bolus of reagent H 2 O 2 (100 μM) (Fig. 2a) . For experiments in Fig. 2b, 6 aliquots of H 2 O 2 (0.5 μM) were added consecutively, and the mixture was incubated for 5 min at 25 °C after addition of each aliquot. For experiments in Extended Data Fig. 5c , the isomer of 1-MT indicated, epacadostat, NLG919 (all 1 mM, final concentration), urate (500 μM), cis-norbixin (130 μM) or the appropriate vehicle was added to rhIDO1, and the reaction started by adding a single bolus of H 2 O 2 (100 μM) together with purified Trp (100 μM). For the experiments in Fig. 2b, Fig. 6b , thiol-blocked IDO1 was generated by treatment with N-ethylmaleimide (NEM). Specifically, IDO1 (40 μM) was incubated with 100 mM NEM for 10 min in the dark. Excess NEM was then removed by centrifuging the reaction mixture in a pre-washed 3K nanosep centrifugal device (Pall) at 14,000g for 10 min at 4 °C. The protein concentration of the NEM-alkylated IDO1 was then determined by spectrophotometry before use.
Detection and quantification of Trp oxidation products by LC-MS/MS.
Chemical and enzymatic reaction mixtures as well as tissue homogenates were analysed using an Agilent 1290 UHPLC system connected to an Agilent 6490 triple-quadrupole mass spectrometer equipped with an ESI source operating in positive-ion mode. For qualitative analysis, samples (5 μl) were separated on a 5-μm Luna C18(2) column (150 × 2.10 mm; Phenomenex) by gradient elution using mobile phase A (0.1% acetic acid in H 2 O) and mobile phase B (0.1% acetic acid in acetonitrile) at 0.2 ml min . However, the gradient consisted of 0-5% mobile phase B from 0-6 min, 5-100% mobile phase B from 6-8 min. Mass spectrometer parameters were as follows: gas temperature = 250 °C; gas flow = 20 l/min; nebulizer pressure = 35 psi; sheath gas heater = 325 °C; sheath gas flow = 12 l/min; capillary voltage = 3,500 V. For full scan studies, the mass spectrometer was set to scan 100-1,000 m/z range, whereas for product ion studies the instrument was set to capture and fragment the largest ion in the peak. Detection and quantification of Trp metabolites was by multiple reaction monitoring using the above general mass spectrometry parameters with fragmentor voltage at 380 V and cell accelerator voltage at 5 V. In each case the largest fragment ion generated by collision-induced dissociation of the [M + H] NMR spectroscopy studies. One-and two-dimensional NMR spectra were recorded at 300 K using a Bruker Avance III 400, 500 or 600 MHz spectrometer.
1 H and 13 C NMR chemical shifts are reported in p.p.m. and are referenced to the residual signal of D 2 O (4.79 p.p.m.). NOE-difference experiments were carried out by irradiation of the peak of interest and allowing for the development of the NOE signal. A blank spectrum was obtained by irradiation at a region in the spectrum not containing any peaks. The subsequent NOE difference spectrum was obtained by subtracting the blank from the spectrum of interest. Detection of 2-chloroethidium as a marker of hypochlorite. Formation of hypochlorite by rhIDO1 in the presence of H 2 O 2 was assessed by the conversion of hydroethidine (HE) to 2-chloroethidium (2-Cl − E + ) by LC-MS/MS as previously described 44 .
Detection of hydroperoxides.
Hydroperoxides were determined by HPLC with post-column chemiluminescence detection using the luminol-microperoxidase method of lipid hydroperoxides 14, 45 . Trp-derived hydroperoxides were separated on a Luna C18(2) (150 × 4.6 mm; 5 μm) column (Phenomenex) using 0.1% acetic acid in H 2 O at 1 ml min −1
. Flow was directed into a UV detector set at 230 nm and then subsequently mixed with a reaction solution containing 1 mM isoluminol, 2 mg/l microperoxidase in 20% methanol and 19% borate buffer, pH 10 at 1.5 ml min −1
. The flow of the reaction mixture was then directed into a chemiluminescence analyser (CLD-100; Tohoku Electronic Industrial) with gain = 1 and attenuation = 8. Detection of dityrosine. Following reaction with H 2 O 2 , rhIDO1 was separated by size exclusion chromatography on a BioSep 3000 (300 × 7.8 mm) column (Phenomenex) using 50 mM potassium phosphate buffer pH 6.8 at 1 ml min −1 using an Agilent 1200 quaternary pump. Flow was directed into a UV detector set at 214 nm and detection of dityrosines performed on a fluorescence detector with excitation set at 325 nm and emission at 410 nm. Detection of urate and parabanic acid. Parabanic acid (PA) and urate (UA) were determined as previously described 24 . Samples were analysed using an Agilent 1290 UHPLC system connected to an Agilent 6490 triple-quadrupole mass spectrometer equipped with an ESI operating in negative ion mode. For analysis, samples (2 μl) were separated on a 5-μm Devosil C30-UG column (Nomura Chemical; 250 mm × 4.6 mm) by isocratic elution using 0.0025% formic acid in H 2 O at 0.8 ml min . Mass spectrometer parameters were as follows: gas temperature = 290 °C; gas flow = 11 l/min; nebulizer pressure = 60 psi; sheath gas heater = 400 °C; sheath gas flow = 12 l/min; capillary voltage = 2,000 V; column compartment = 40 °C. Detection and quantification of PA and UA was by multiple reaction monitoring using the above general mass spectrometry parameters with fragmentor voltage at 380 V and cell accelerator voltage at 5 V. Settings for the target analytes were (parent ion → fragment ion); PA (m/z 113 → 42) with CE = 13 V; UA (m/z 167 → 123) with CE = 13 V. Chromatographic retention times for PA and urate were 5.8 and 13.0 min, respectively. All analytes were quantified by area comparison with authentic commercial standards. Data acquisition and analysis were performed as described above for tryptophan oxidation products. Detection and quantification of 1 O 2 . Fluorescence detection of 1 O 2 by SOSG (5 mM stock solution) was performed in 96-well black-walled plates (Costar) at 25 °C. In brief, SOSG (100 μM) and then H 2 O 2 (100 μM) were added to 2 μM human serum albumin, 1 μM rhIDO1, 1 μM rhIDO1 plus 100 μM Trp, or 1 μM rhIDO1 plus 500 μM urate in 100 mM phosphate buffer pH 7.4 in the presence of 100 μM DTPA. Fluorescence of SOSG-endoperoxide was then detected using the PHERAstar plate reader (BMG Labtech) with excitation and emission set at 485 and 520 nm, respectively. Where indicated, rhIDO1 was pretreated for 30 min at 37 °C with 100 mM CORM-A1, 10 μM DEANO or iCORM-A1 before exposure to SOSG-H 2 O 2 . iCORM-A1 was generated as previously described 46 . 1 O 2 was quantified by the conversion of EAS to its 1 O 2 -specific product (EAS-O 2 , synthesized as described 47 ). Mixtures of rhIDO1 (2 μM) and EAS (8 mM) ± H 2 O 2 (100 μM) were incubated under aerobic conditions for 5 min at 25 °C before the conversion of EAS to EAS-O 2 was determined by LC-MS/MS as described below. At the concentration used, EAS traps 50% of available 1 O 2
48
. To quantify cis-WOOH, EAS was replaced in these reactions with purified Trp and the hydroperoxide quantified by LC-MS/MS as described above. EAS and EAS-O 2 were detected as previously described 16 with minor modifications. The analytes were separated at a flow rate of 0.8 ml min −1 using a Luna C18(2) reverse-phase column, 250 × 4.6 mm, 5 μm (Phenomenex) using 25 mM ammonium formate (mobile phase A) and acetonitrile:methanol 7:3 v/v (mobile phase B) with linear gradient of 25% B from 0-15 min, 25-70% B from 15-16 min, 70% B from 16-25 min, 70-25% B during 1 min and finally equilibrated at 25% B for 9 min. Ionization of the sample was by ESI in the negative ion mode using the following parameters: gas temperature = 290 °C; gas flow = 1 l/min; nebulizer pressure = 20 psi; sheath gas heater = 350 °C; sheath gas flow = 11 l/min; capillary voltage = 3,500 V and nozzle voltage = 500 V. EAS and EAS-O 2 were detected by multiple reaction monitoring with fragmentor voltage at 380 V and cell accelerator voltage at 5 V using the following transitions m/z 212 → 97 (CE = 10V) and m/z 228 → 212 (CE = 10V), respectively. Data acquisition and analysis were performed as described above for tryptophan oxidation products.
Phosphorescence corresponding to the 1 O 2 monomol light emission was monitored with a special FLSP 920 photocounting apparatus (Edinburgh Instruments) suitable for emissions in the NIR region (800-1,400 nm), which enabled the monitoring of the kinetics of formation and decay of 1 O 2 at 1,270 nm using a detector coupled to a Hamamatsu H10330A-45 apparatus (Hamamatsu Photonics K.K.) cooled to −60 °C, with the applied potential set to −0.8 kV 16 . In a typical experiment, 50 μM H 2 O 2 was added to D 2 O in a quartz cuvette (4 mm × 10 mm × 30 mm) in the dark and the reaction started by the addition of 1 μM rhIDO1 in a final volume of 300 μl. Thermal decomposition of DHPNO 2 (endoperoxide of N,N-di(2,3-dihydroxypropyl)-1,4-naphthalene dipropanamide), which generates high yields of 1 O 2
47
, was used as control with monomol light emission recorded at 1,270 nm. Where indicated, D 2 O was replaced with H 2 O, Trp was added after rhIDO1, or the reaction was carried out under anaerobic conditions by bubbling the mixture with N 2 (99.9%, Air Products). Alternatively, the solution of rhIDO1 was bubbled with CO (1,400 p.p.m./N 2 , Air Liquide) or NO (99%, Linde) to examine the effect of these gaseous molecules on IDO1-H 2 O 2 -mediated formation of 1 O 2 . Spectrophotometric studies. cis-WOOH stability studies were performed by incubating cis-WOOH in 100 mM phosphate buffer pH 7.4 at 37 °C with spectra (190 to 400 nm) recorded (Agilent Cary 100) every 5 min for 150 min against a blank of phosphate buffer. UV-visible light emission studies were performed by incubating 3.6 mM cis-WOOH in D 2 O phosphate buffer (200 mM) at 72 °C and emission recorded by a FLSP 920 photon counter (Edinburgh Instruments) consisting of two UV-visible Hamamatsu detectors R9110 (190-700 nm), maintained at −20 °C by a CO1 thermoelectric cooler (Edinburgh Instruments). The detector used to measure the steady-state light emission from cis-WOOH was not preceded by a monochromator, so that light was recorded directly from the cuvette source. To trace the cis-WOOH-elicited chemiluminescence spectrum, a second detector was used and its wavelength was determined using a monochromator. Dimerization of human recombinant PKG1α. Purified human recombinant wild-type and C42S mutant PKG1α 49 (5 μM) was reduced in an anaerobic chamber (Saffron Scientific Equipment) with 50 mM DTT and buffer exchanged into 10 mM HEPES pH 7.4 and 150 mM NaCl immediately before oxidation with Trp-derived hydroperoxides. Reactions were quenched with non-reducing SDS sample buffer containing 25 mM NEM, then proteins were separated by SDS-PAGE and visualized by colloidal Coomassie staining. Animals and animal tissue. All experiments involving animals or rodent tissues complied with the ethical regulations of, and were approved by, the Animal Ethics Committees of the Garvan Institute of Medical Research/St Vincent's Hospital, the University of Sydney and the King's College London. For porcine coronary arteries, we sourced freshly isolated adult pig hearts from a local abattoir (Wollondilly Abattoir). Experiments were carried out double-blinded without randomization, and with sample sizes chosen based on previous experiments of similar nature 6 . We used 8-12-week-old male and female C57BL/6J and Apoe −/− mice on a C57BL/6J background (Animal Resources Centre),
Ido1
−/− on a C57BL/6J background 50 and PKG1α(C42S) knock-in mice 28 as well as their corresponding C57BL/6N wild-type controls, and 10-to 14-week-old male and female Wistar rats (Animal Resources Centre). Ido1 −/− mice were obtained from homozygous knockout breeding, whereas PKG1α(C42S) knock-in mice were obtained from heterozygous breeding using littermate wild-type controls. Ido1
Ido2
−/− mice were produced by the Mouse Engineering Garvan/ ABR (MEGA) Facility using CRISPR-Cas9 gene targeting in C57BL/6J mouse embryos following established molecular and animal husbandry techniques 51 . Two single-guide RNAs (sgRNAs) were used that targeted Cas9 to exon 4 of Ido1 (TTCTCTGAGAGCTCGCAGTAGGG, protospacer-associated motif (PAM), underlined) and exon 4 of Ido2 (CTTGGGACTCCCGCCTATCCTGG). A solution consisting of the two sgRNAs (15 ng μl −1 each) and full-length, polyadenylated Streptococcus pyogenes Cas9 mRNA (30 ng μl −1 ) was prepared and microinjected into the nucleus and cytoplasm of C57BL/6J zygotes. Microinjected embryos were cultured overnight and those that underwent cleavage introduced into pseudo-pregnant foster mothers. Pups were screened by PCR across the target sites and Sanger sequencing of PCR products used to detect mice carrying frame-shift deletions in both Ido1 and Ido2. Following backcrossing to C57BL/6 wild-type mice, heterozygous Ido1
+/− mice were identified that carried 17-bp deletion and a 1-bp insertion in exon 4 of Ido1 and Ido2, respectively, that were linked on the same copy of chromosome 8. These mice were bred for further analysis. For porcine coronary arteries, hearts obtained freshly from the local abattoir were placed in ice-cold Krebs-Henseleit buffer, containing 200 U ml −1 penicillin and 200 μg ml −1 streptomycin, and transported to the laboratory for isolation of coronary arteries. Rat mesenteric, coronary and cerebral arteries were obtained as part of a tissue sharing arrangement from M. Duebbert and J. Villanueve (Victor Chang Cardiac Research Institute). Third-order mesenteric arteries were taken from Wistar rats of mixed age and sex, whereas coronary and cerebral arteries were taken from spontaneously hypertensive rats of mixed age and sex. Once collected, arteries were placed briefly in ice-cold Krebs-Henseleit solution before myography experiments. Endotoxaemia was induced in 8-to 12-week-old male C57B/6J mice (except for experiments described in Fig. 4d-f , for which C57B/6N control and PKG1α(C42S) knock-in mice on C57B/6N background 28 were used) by intra-peritoneal injection Letter reSeArCH of 5-10 mg per kg body weight LPS (0111:B4, Sigma-Aldrich L4130). Twelve to sixteen hours after LPS administration, anaesthesia was induced using isofluorane before blood pressure determination or collection of arteries. Arteries were collected after cardiac puncture, exsanguination and perfusion using sterile PBS.
For transverse aortic constriction (TAC) studies, size (30.5 ± 1.9 g) and agematched (110 ± 1 day) male C57BL/6J mice were randomly assigned to sham or TAC surgery. Mice subjected to TAC surgery were placed under anaesthesia using isoflurane and an incision was made into the thorax, exposing the transverse aorta. A 7-0 prolene suture was then placed around the transverse aorta and the constriction sized using a 27-gauge needle. Sham operations consisted of passing the suture around the transverse aorta and removing without constriction. Mice were euthanized 21 days after surgery and tissues were taken for biochemical and quantitative PCR analyses. Left ventricular hypertrophy was determined by weighing the left ventricle and normalizing the weight to the length of the left tibia.
For atherosclerosis studies, male and female 8-to 12-week-old Apoe −/− and Apoe −/− Ido1 −/− mice were fed a Western diet (SF00-219, Speciality Feeds) for six months before assessment of vascular tone, blood pressure and immunohistochemistry. The SF00-219 diet is based on Harlan Teklad TD88137 Western diet and contains 22% fat and 0.15% cholesterol. Blood pressure. Systolic blood pressure in LPS-treated PKG1α(C42S) knock-in and corresponding wild-type (C57B/6N) mice was determined using micromanometry as previously described 52 , with the following modification. Twelve hours after administration of LPS (5 mg/kg), an incision was made in the neck of anaesthesized mice to expose and dissect the left carotid artery and right jugular vein from circumferential connective tissues before administration of atropine (0.5 mg/ kg) into the right jugular vein to inhibit vagal reflex. A 1.2F solid-state catheter (4.5-mm electrode spacing; Transonic) was then inserted into the left carotid artery to measure systolic blood pressure in the aorta. After establishing baseline parameters, systolic blood pressure was recorded in response to intravenous (right jugular vein) infusion of purified Trp (8 mM, final blood concentration), vehicle control or SNP (1 μM). Each mouse was exposed to Trp, vehicle and SNP with a 2-min rest period between each addition, to allow blood pressure to return to baseline. All blood pressure experiments were performed double-blinded regarding genotype.
Systolic blood pressure in conscious Apoe −/− and Ido1
Apoe −/− mice was recorded as previously described 6 , using a computerized, non-invasive tail-cuff system (BP 2000 Blood Pressure Analysis System, Visitech Systems) that gives results that correlate closely with intra-arterial measurements 53 . An initial ten inflationdeflation cycle was used for each mouse to set amplifier and instrument controls. Subsequently, ten readings were averaged for a single session value. Systolic blood pressure was recorded before and 1 h after intra-peritoneal administration of 1 ml of 20 mM 1-d-methyltryptophan (1-D-MT, an IDO1 inhibitor). Arterial-relaxation studies. After dissection, arteries were placed immediately in ice-cold Krebs-Henseleit (Sigma-Aldrich K3753, supplemented with 2.5 mM CaCl 2 , 10 mM EDTA, 2.1 mg ml −1 sodium bicarbonate and adjusted to pH 7.4), or MOPS buffer (145 mM NaCl, 4.7 mM KCl, 2 mM CaCl 2 , 1.17 mM MgSO 4 , 2 mM MOPS, 1.2 mM NaH 2 PO 4 , 5 mM d-glucose, 2 mM sodium pyruvate, 0.02 mM EDTA and 2.75 mM NaOH to adjust pH to 7.4) before further analysis. Isolated conduit and resistance arteries were used either immediately after dissection (naive, LPS-treated mice or mice fed with a Western diet for 6 months; naive rats; porcine arteries) or after 48 h incubation at 37 °C in M199 medium containing 200 U ml −1 penicillin, 200 μg ml −1 streptomycin, and l-N G -nitroarginine methyl ester (l-NAME, 100 μM) in the presence or absence of 400 ng ml −1 of recombinant IFN-γ of the relevant species to induce IDO1 expression. Arterial rings were then mounted in Krebs-Henseleit buffer onto 25-μm or 40-μm wires in a multiwire myograph system (Model 610M, Danish Myo Technology). The 25-μm wires enable working with vessels as small as ~80 μm internal diameter. To assess microvascular function in the present study, we used third-order mesenteric arteries of 100-200 μm, taken between the base of the mesentericarterial arcade and the gut wall 54 . To establish passive tension, aortas were subjected to a length-tension protocol as previously described 6 , whereas resistance arteries were normalized to 90% of the internal circumference obtained at 100 mm Hg 55 . Once passive tension was established, arteries were stimulated with KCl (60 or 120 mM) and then washed out and allowed to equilibrate to baseline tension for 30 min. Arteries were then constricted sub-maximally using noradrenaline or U46619 at a concentration that caused 80% of the respective agent's maximal constriction (EC 80 ). After stable tone was achieved, acetylcholine, purified Trp (8 mM), NFK, Kyn, or 1 O 2 -exposed Trp and its purified products including cis-WOOH were added either as a bolus or in a concentration-dependent manner, in the presence or absence of 1 mM 1-MT. l-NAME (100 μM) and indomethacin (10 μM) were added to the buffer and present throughout the experiment for endothelium-intact arteries. Where indicated, arteries were denuded via luminal perfusion with 100 μl Triton X-100 (0.1% v/v) for 10 s, followed by 100 μl of Krebs-Henseleit buffer to negate the effects of the endothelium. Denudation was confirmed by <10% response to acetylcholine (0.1-10 μM). At the end of each experiment, arteries were stimulated with the endothelium-independent relaxant SNP (10 μM) and arteries were deemed viable if responses of ≥ 80% maximal relaxation were observed. Measurement of arterial H 2 O 2 . Arterial H 2 O 2 was measured by the aminotriazole-inhibitable catalase activity assay 56 . In brief, naive or IFN-γ-treated (400 ng ml −1 ) porcine arterial rings were incubated in the presence or absence of 3-amino-1,2,4-triazole (20 mM) for 48 h at 37 °C. Aminotriazole covalently binds to the catalytic haem and thereby inactivates catalase engaging in H 2 O 2 metabolism. Arterial rings were then washed twice with MOPS buffer, immediately snap-frozen in liquid N 2 , pulverized and then homogenized in 1 ml of homogenization buffer (100 mM phosphate buffer pH 7.4 containing 100 μM EDTA, 100 μM DTPA and Triton X-100, 0.1% v/v) using 3 × 1-min bursts at 7,000 r.p.m. (Heidolph homogenizer). Homogenates were centrifuged for 15 min at 1,000g at 4 °C and 40 μl of supernate was added to 950 μl homogenization buffer in a quartz cuvette placed in an Agilent Cary 100 spectrophotometer at 25 °C. Catalase activity was then determined by monitoring the decrease in absorbance at 240 nm over 15 min following the addition of H 2 O 2 (10 μl, 20 mM final concentration). The amount of H 2 O 2 in the arteries was calculated as the difference in the loss of catalase activity between untreated and aminotriazole-treated tissue, and expressed per min and mg protein. Protein quantification in samples was determined by using BCA as per the manufacturer's instructions. Detection of labelled cis-WOOH in porcine arteries. Left anterior-descending coronary arteries were dissected from pig hearts. Arteries were cut into 2-mm-wide rings and placed in M199 medium containing penicillin and streptomycin, Fungizone (amphotericin B 2.5 μg ml ; Invitrogen) and l-NAME (100 μM). After incubation for 48 h at 37 °C in 95% air with 5% CO 2 in the absence or presence of 200 or 400 ng ml −1 recombinant porcine IFN-γ, rings were washed twice with MOPS buffer containing DTPA (100 μM) and NEM (1 mM), and then incubated for 60 min at 37 °C in 95% air 5% CO 2 in MOPS buffer containing DTPA (100 μM), NEM (1 mM), l-NAME (100 μM) and indomethacin (10 μM). After addition of noradrenaline (3 μM final concentration), rings were incubated for further 20 min before addition of 15 N 2 Trp (6 mM). After 6 min, rings were removed from the buffer and snap-frozen in liquid N 2 . Rings were then pulverized on liquid N 2 using mortar and pestle, followed by addition of 2 ml of ice-cold HPLC-grade H 2 O containing 2× protease inhibitor cocktail, NEM (1 mM) and trans-WOOH (10 μM, as internal standard), and homogenized on ice using 5 × 1 min bursts at 7,000 r.p.m. (Heidolph homogenizer). Homogenates were then centrifuged at 3,220g for 10 min at 4 °C, the supernate removed and re-centrifuged for a further 10 min at 17,000g at 4 °C. Five microlitres of supernate were then subjected to LC-MS/MS to detect 15 N 2 cis-WOOH. Protein concentration in samples was determined by using the BCA assay as per the manufacturer's instructions. Detection of parabanic acid in porcine arteries. Left anterior-descending coronary arteries were dissected from porcine hearts. Arteries were cut into 2-mm-wide rings and placed in M199 medium containing penicillin, streptomycin, Fungizone and l-NAME as described above. After incubation for 51 h at 37 °C in 95% air with 5% CO 2 in the absence or presence of recombinant porcine IFN-γ (400 ng ml −1 ), rings were washed twice with MOPS buffer containing DTPA (100 μM) and then incubated for 8 h at 37 °C in 95% air with 5% CO 2 in MOPS buffer containing DTPA (100 μM), l-NAME (100 μM) and indomethacin (10 μM). After addition of noradrenaline (3 μM final concentration), rings were incubated for further 20 min, washed twice with 100 mM phosphate buffer pH 7.4, before addition of 100 mM phosphate buffer pH 7.4 containing 500 μM urate. After 5 min, purified Trp was added (8 mM) and rings were incubated for a further 5 min before being removed, blotted dry, weighed and snap-frozen in liquid N 2 . Rings were pulverized on liquid N 2 using mortar and pestle, followed by addition of 2 ml ice-cold 100 mM phosphate buffer pH 7.4 containing 2× protease inhibitor cocktail, and then homogenized on ice using 5 × 1 min bursts at 7,000 r.p.m. (Heidolph homogenizer). Homogenates were then centrifuged at 3,220g for 10 min at 4 °C, the supernate removed and re-centrifuged for further 10 min at 17,000g at 4 °C. Two microlitres of supernate were then subjected to LC-MS/MS to detect parabanic acid. SDS-PAGE, silver stain and carbonyl detection. rhIDO1 (2 μM) and H 2 O 2 (100 μM) were incubated in the absence and presence of Trp (100 μM) and/or 5,5-dimethyl-1-pyrroline N-oxide (DMPO, 20 mM) and equal amounts of the reaction mixtures then subjected to SDS-PAGE using 10% poly-acrylamide gels and SeeBlue Plus2 pre-stained protein standard as molecular mass standards. Electrophoresis was performed at 200 V for 45-60 min and separated proteins were visualized by silver staining. Alternatively, protein carbonyls were detected after derivatization with dinitrophenylhydrazine using the OxyBlot kit (Millipore). RT-PCR for IDO1 detection in transaortic constriction tissues. Total RNA was extracted from the left ventricle of sham-and TAC-operated mice using TRIzol reagent. Left ventricle isolated from a wild-type mouse and exposed to IFN-γ for 48 h was used as positive control for IDO1 expression. Reverse transcription was carried out using the Superscript IV first strand cDNA synthesis system. Quantitative real-time PCR was performed on a LightCycler 480 instrument (Roche) using the SensiFAST SYBR NO-ROX kit (Bioline) as per manufacturer's protocol. Data were normalized to the housekeeping gene Hprt using the comparative CT method 57 . Melt curve analysis was used to confirm that all PCR reactions produced a single product. The primers used in real-time PCR were: Ido1 forward, CCCACACTGAGCACGGACGG; Ido1 reverse, TTGCGGGGCAGCACCTTTCG; Hprt forward, GCTTTCCCTGGTTAAGCAGTACA; Hprt reverse, CAAACTT GTCTGGAATTTCAAATC. Western blotting. Dimerization of PKG1α was assessed by western blot analysis as previously described 28 with minor modifications. For arterial tissue, aortas or mesenteric arteries isolated from mice were placed in MOPS buffer, incubated at 37 °C for 20 min, stimulated with ~EC 80 noradrenaline for 20 min and then treated with a bolus of HPLC-purified Trp (8 mM) or metabolites thereof (1 mM), H 2 O 2 (positive control, data not shown), or vehicle for 3 min. Arteries were snap-frozen and placed in 10 μl NEM (100 mM) then pulverized on liquid N 2 , suspended in RIPA buffer (150 mM NaCl, 50 mM Tris-HCl, 5 mM EDTA, 1% sodium deoxycholate, 0.1% SDS, 1% Triton X-100) supplemented with protease inhibitors and then subjected to two cycles of freezing (in liquid N 2 ) and thawing. Non-reducing SDS sample buffer was then added to homogenates, the samples heated at 90 °C for 10 min, and then centrifuged at 11,000g for 5 min. The resulting supernate was removed and centrifuged again for 5 min at 11,000g, after which an equal volume of supernate was loaded onto 10% polyacrylamide gels. Electrophoresis was performed at 200 V for 1 h and separated proteins were transferred onto nitrocellulose membranes at 20-25 V in a stepwise manner for 7 min using the iBlot 2 Dry Blotting System (Thermo Fisher Scientific). Blotted membranes were blocked in 10% (w/v) skim milk powder with 0.1% (v/v) Tween-20 in Tris-buffered saline for 1 h at room temperature. Blocked membranes were then probed overnight at 4 °C with rabbit polyclonal anti-PKG antibody (1:1,000 v/v, ENZO Life Sciences ADI-KAP-PK005) in 10% (w/v) skim milk and Tween 20-containing Tris-buffered saline, followed by 1 h incubation with horseradish peroxidase-conjugated IgG (1:2,000 dilution, v/v, Dako P0448) at room temperature in 10% skim milk and 0.1% Tween 20 in Tris-buffered saline. Protein bands were detected by enhanced chemiluminescence according to the manufacturer's instructions (ECL detection reagent and Hyperfilm ECL, GE Healthcare BioSciences) and analysed by densitometry using the Image Studio Lite (LI-COR). To examine the effects of cis-WOOH on PKG1α dimerization in arteries of Ido1 −/− mice, the above method was modified slightly. Samples were not heated or subjected to freeze thawing. Samples were run on 4-20% polyacrylamide gels (Mini-PROTEAN TGX, Bio-Rad), electrophoresis was performed at 200 V for 1 h and separated proteins were transferred onto 0.2-μm nitrocellulose membranes (Bio-Rad) at 2.5 A for 10 min using the Trans-Blot Turbo Blotting System (Bio-Rad). Immunoblotting was then performed as described above.
For human aortic vascular smooth muscle cells (HASMC, Lonza CC-2571), cells (passage numbers 3-5) were cultured in Smooth Muscle Growth Medium-2 with BulletKit (SmGM, Lonza), grown to confluence in 12-well plates and incubated for 72 h in SmGM in the absence and presence of 100 ng ml −1 recombinant human IFN-γ (rhIFN-γ) to induce IDO1 expression 58 . Cells were authenticated by Lonza and tested (negative) for mycoplasma contamination. Medium was then replaced with Hank's Buffered Saline Solution for 2 h before pretreatment of the cells with or without 10 μM epacadostat or vehicle (0.1% DMSO) for 30 min. HASMC were then treated for 5 min with purified Trp (8 mM) and/or H 2 O 2 at the concentration indicated, washed twice with cold phosphate-buffered saline (PBS) and lysed directly into non-reducing SDS sample buffer containing 100 mM NEM. Samples were centrifuged at 11,000g for 10 min and 10 μl of supernate loaded onto 4-20% polyacrylamide gels (Mini-PROTEAN TGX, Bio-Rad). Electrophoresis was performed at 200 V for 1 h and separated proteins were transferred onto 0.2-μm nitrocellulose membranes (Bio-Rad) at 2.5 A for 10 min using the Trans-Blot Turbo Blotting System (Bio-Rad). Membranes were blocked in 10% (w/v) skim milk powder with 0.1% (v/v) Tween 20 in Tris-buffered saline for 1 h at room temperature. Blocked membranes were probed overnight at 4 °C with rabbit polyclonal anti-PKG antibody (1:1,000 v/v) or rabbit monoclonal anti-IDO1 (1:5,000 v/v, Cell Signalling 86630) in 10% (w/v) skim milk and Tween 20-containing Tris-buffered saline. Following this, membranes were incubated with horseradish peroxidaseconjugated IgG (1:2,000 dilution, v/v) at room temperature in 10% skim milk and 0.1% Tween 20 in Tris-buffered saline for 1 h. Protein bands were detected and analysed as described above. Immunohistochemistry and atherosclerosis lesion assessment. Expression of IDO1 protein in atherosclerotic lesions from mouse thoracic aortas and kidney was assessed using a rabbit polyclonal antibody to mouse IDO1 6 (KR101 
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Policy information about availability of computer code Data collection LC/MS data was collected using Agilent Technologies MassHunter Workstation software (for synthesis of Epacadostat, version B.05.00 Build 5.0.5042.2 was used and analysis was performed using Mass Hunter Qualitative Analysis version B.05.00 Build 5.0.519.13; for detection and quantification of Trp oxidation products by LC-MS/MS, version B.06.00 Build 6.0.6025.0 was used and analysis was performed using Mass Hunter Qualitative Analysis version B.06.00 Build 6.0.633.10 Service pack 1). HPLC/UV detection data was collected using PerkinElmer TotalChrom software. Spectrophotometric data was collected using Agilent Technologies Cary WinUV software. Data from fluorescence experiments were quantified using PHERAstar FS MARS. NMR data was collected using Bruker Topspin software. Arterial relaxation data was collected using ADI Lab Chart 5 and 8 software. Micromanometry blood pressure data was acquired using Biopac systems AcqKnowledge software, tail cuff blood pressure data was acquired using Visitech Systems BP-2000 blood pressure analysis system software. Western blot densitometry data was collected using Li-cor biosciences image studio lite. Data from singlet oxygen light emission experiments was collected using L900 software version 7.2.4 Edinburgh Analytical Instruments, Livingston, U.K. Chemical structures were drawn using ChemDraw Professional 17.0.
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Data were analyzed using Microsoft Excel version 16.12 and Prism 7 version 7.0d software.
For manuscripts utilizing custom algorithms or software that are central to the research but not yet described in published literature, software must be made available to editors/reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub Data exclusions In arterial relaxant studies arteries were validated by their ability to relax ≥80 to a nitric oxide donor at the end of the experiment. In arteries were the endothelium was removed, successful removal was validated by increased response to noradrenaline and ≤10% response to acetylcholine. Any arteries which failed to fulfill these pre-established criteria were excluded from analysis.
Replication
Reproducibility of the experimental findings was verified by using positive and negative controls to test intra-and inter-day variation. If a positive control did not provide a signal or result in a pre-specified range the assay on the day was deemed not reproducible and test samples were thus not tested or, if tested, data not analysed nor included in final results. Experiments would then be repeated to ensure that positive and negative (where required) controls provided data within reasonable pre-specified range (usually 20% inter-day variation and 10% intraday variation).
Randomization Where feasible samples were randomly assigned to treatment groups.
Blinding
Blinding was conducted were feasible. Specifically, for blood pressure experiments, the operator was blinded during the experiment and analysis
Reporting for specific materials, systems and methods We used male and female mice between the ages of 8-12 weeks of age that were either wild type C57BL6/J, IDO1-/-on a C57BL6/J background, wild type C57BL6/N or PKG1a C42S mutant mice on a C57BL6/N background. We used 10-14 week old mixed sex Wistar rats. We also used porcine coronary arteries collected from a local abattoir from medium sized pigs of mixed age and sex.
Wild animals
No wild animals were used
Field-collected samples
No field samples were collected
